UC-MSC Derived Exosome Therapy
Your cells already know how to heal. Exosome treatment reminds them.
What Are Exosomes
Biological messengers, not cells.
Exosomes restore what aging, illness, and chronic inflammation disrupt: the body’s cellular communication network.
Exosomes are extracellular vesicles (EV) — structures cells release naturally as part of how they communicate with each other. Each one carries a precise cargo: proteins, growth factors, lipids, and RNA molecules that instruct nearby cells to reduce inflammation, speed up repair, and restore biological balance.
They’re not cells. They don’t divide or engraft into tissue. Instead, they act as messengers, targeting cells that have lost the ability to communicate effectively, a breakdown that underlies chronic illness, immune dysregulation, and accelerated aging.
At OmniStem, exosomes come exclusively from Wharton’s Jelly-sourced umbilical cord derived exosomes – mesenchymal stem cell exosomes processed in our own GMP-aligned laboratory in Punta Cana, under Ministry of Health oversight.
Why UC-MSC Derived
The source determines the quality.
OmniStem sources exosomes from umbilical cord tissue, specifically Wharton’s Jelly, the connective tissue inside it. This source gives us cells with a low immunogenic profile, high proliferative capacity, and a richer signaling payload than adult-derived alternatives like adipose or bone marrow tissue.
Donor tissue is collected non-invasively, with documented informed consent. Every batch is triple-tested for sterility, viability, and identity before release, and every patient receives a Certificate of Analysis on departure.
The result: a biologic with documented origin, consistent quality, and minimal immune risk, administered under physician supervision, from the same facility where it was produced.
Cellular structure and bioactive components of exosomes
How Exosomes Work
Three mechanisms, one signaling system.
Cellular
Signaling
Blood-Brain Barrier Penetration
Immune
Recalibration
Therapeutic Benefits
What UC-MSC derived exosomes are designed to support.
Cellular communication
Restores signaling between cells disrupted by aging, stress, or disease.
Inflammation reduction
Targets chronic and systemic inflammatory load without immunosuppression.
Tissue repair
Activates repair processes in joints, discs, pulmonary tissue, and skin.
Neurological support
Delivers regenerative signals across the blood-brain barrier to the central nervous system.
Immune regulation
Helps recalibrate immune activity in chronic inflammatory and autoimmune conditions.
Aesthetic renewal
Stimulates collagen synthesis and follicular activity, supporting skin rejuvenation and hair growth.
Safety profile
The acellular nature of exosomes eliminates replication risk and reduces the chance of immune rejection. As with any biologic, individual side effects are possible, a physician will review these with you as part of your evaluation.
UC-MSCs and Exosomes — How They Differ
Two biologics, one platform.
Both UC-MSC stem cells and their derived exosomes are part of OmniStem’s core biologic platform. They work through different mechanisms and are often combined within the same protocol to amplify therapeutic effect.
| UC-MSCs Stem Cells | UC-MSC Derived Exosomes Nanoscale Vesicles | |
|---|---|---|
| Structure | Complete cells with nucleus and organelles | Nanoscale vesicles — no nucleus, no organelles |
| Source | Wharton's Jelly, umbilical cord | Secreted by UC-MSCs during culture |
| Mechanism | Integrate near damaged tissue; secrete anti-inflammatory and regenerative factors | Deliver molecular cargo to recipient cells; modulate communication and inflammation |
| Differentiation | Can develop into bone, cartilage, muscle, or fat | Do not differentiate — function through signaling only |
| Immunogenic profile | Low | Lower — acellular, no replication risk |
| Blood-brain barrier | Does not cross | Crosses the BBB; relevant for neurological protocols |
| Best for | Structural tissue repair, systemic regeneration, immune recalibration | Neurological support, targeted signaling, aesthetic applications, pulmonary delivery |
| Characteristic | UC-MSCs (Stem Cells) | UC-MSC Derived Exosomes |
|---|---|---|
| Source | Wharton's jelly from the umbilical cord | Extracellular vesicles secreted by UC-MSCs |
| Structure | Complete cells with organelles and nucleus | Nano-sized vesicles without nucleus, only biomolecules |
| Differentiation | Can transform into various cell types | Do not differentiate; act through signaling |
| Mechanism of Action | Integrate and regenerate damaged tissues | Modulate cell communication and reduce inflammation |
| Immunomodulation | Secrete anti-inflammatory factors | Contain molecules that regulate the immune system |
| Therapeutic Uses | Tissue regeneration in osteoarthritis, neurology, autoimmune diseases, and aesthetics | Same therapeutic fields via targeted cell signaling |
In many protocols, exosomes are combined with UC-MSC infusions to amplify the regenerative response. Protocol design is determined individually after medical review.
a newer, actively evolving field.
What Makes This a Cutting-Edge Approach
Exosome therapy represents a relatively recent shift in regenerative medicine, moving from whole-cell transplantation toward the signaling molecules those cells naturally produce. This cutting edge approach is still an active area of research, but it offers a meaningful distinction: because exosomes are acellular, they carry a different risk and delivery profile than a full stem cell infusion, while still working through many of the same biological pathways.
The healing process exosomes are designed to support isn’t instantaneous. Like UC-MSC therapy itself, it unfolds gradually as the signaling molecules do their work, most patients are evaluated over a period of weeks to months to track response, not days.
Clinical Applications
Conditions addressed with exosome therapy.
01
Joint Pain & Sports Injuries
02
Back Pain & Spine Disorders
03
Neurological & Cognitive Support
04
Autoimmune Conditions
05
Pulmonary Health
06
Sexual Wellness
07
Hair Loss (Alopecia)
08
Healthy Aging & Longevity
Stimulates collagen synthesis, reduces systemic inflammatory load, and supports cellular renewal for patients focused on longevity and quality of life.
Administration
Three routes. One clinical standard.
Exosome delivery method is determined by the condition being treated and the therapeutic objective. All administration is physician-performed under clinical supervision.
Route I
Intravenous Infusion
Route II
Targeted Local Application
Route III
Nebulization
FAQ
Frequently Asked Questions
How are exosomes different from stem cells?
Are exosomes safer than stem cells?
Can exosome therapy be combined with other treatments?
Yes. At OmniStem, exosomes are frequently used alongside UC-MSC stem cell infusions, hyperbaric oxygen therapy, ozone therapy, and physiotherapy. Combination protocols are designed to amplify the regenerative response. The appropriate combination is determined individually after clinical review.
What exosome surface markers does OmniStem use?
UC-MSC-derived exosomes carry characteristic surface markers including CD9, CD63, CD81, CD73, CD90, and CD105, along with a cargo of microRNA, mRNA, structural proteins, and bioactive lipids. Identity characterization is part of our triple-testing protocol for every batch.
When can I expect results?
Can UC-MSC therapy be combined with other treatments?
Yes, but only under medical supervision. Certain medications, such as anti-inflammatory or steroid drugs, must be paused before and after treatment to avoid interference.
Do I need multiple treatments?
This depends on the condition, its severity, and individual clinical response. Some patients achieve their therapeutic objectives with a single treatment. Others benefit from follow-up sessions. The medical team monitors progress and makes recommendations based on your response to the initial protocol and your long-term clinical goals.
Why Punta Cana?
These therapies are available in the Dominican Republic under physician supervision and Ministry of Health oversight. They are not currently approved for clinical use in the United States or European Union. OmniStem operates within a regulated legal framework, and is located minutes from Punta Cana International Airport, with concierge coordination for reception, transport, and accommodation throughout your stay.
BEGIN YOUR EVALUATION
Your case. In our hands.
Within 48 hours.
A physician on the OmniStem medical team will review your clinical profile individually and prepare an initial assessment. What follows is a medical conversation, no obligation.
